For Billion-Dollar COVID Vaccines, Basic Government-Funded Science Laid the Groundwork
Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits
Stories by Kaiser Health News
Biden’s Health Agenda Dims with GOP Likely to Hold Senate
Joe Biden won the election, but Senate Republicans could block his attempts to expand the Affordable Care Act
How the Election Could Affect Health Care and Drug Policy
The outcome could have important consequences for Medicaid, abortion access, and legalization of marijuana and other drugs
Billions of Dollars for Stem Cell Research Institute On California’s November Ballot
Voters must decide whether to keep financing the second largest funder of stem cell science in the world
How Ginsburg’s Death Threatens the Affordable Care Act and Reproductive Rights
As the Trump administration eyes a speedy replacement, the court will hear a case against the health care law a week after the election
COVID-19 and Smoke Inhalation Symptoms Are Hard to Tell Apart
Whether it’s a cough or a sore throat, doctors in areas affected by the recent wildfires must determine whether symptoms are caused by the coronavirus, smoke or even the flu
NIH ‘Very Concerned’ about Serious Side Effect in Coronavirus Vaccine Trial
The test was halted when a participant suffered spinal cord damage, and U.S. scientists launched an investigation
College Coronavirus Testing Plans Are All Over the Map
With no clear guidance from the federal government, schools are pursuing a mix of online and in-person classes
How to Know If It’s OK to Visit Your Favorite Store or Restaurant
Public health experts offer tips for evaluating the risks of visiting public places during the COVID-19 pandemic
Thousands Volunteer for COVID-19 Vaccine Study
Late-stage clinical trials of the first two coronavirus vaccine candidates in the U.S. plan to recruit 60,000 Americans
Fauci Optimistic About COVID-19 Vaccines, Though Immunity Unknowns Complicate Development
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
Vaccine Trials Should Reflect America’s Diversity
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials...
Trump Administration’s Sudden Shift on COVID-19 Data Leaves States in the Lurch
The White House told hospitals to report data through a private company system instead of the Centers for Disease Control and Prevention
Easy to Say ‘Get Tested’ for the Coronavirus—Harder to Do: Here’s How
Experts explain the best time for testing after exposure and how to find test sites
COVID-19 Worsens Obsessive-Compulsive Disorder—but Therapy Offers Coping Skills
The pandemic has heightened OCD phobias such as fear of germs. Yet some patients say experience with anxiety, and treatment for it, gives them an advantage
Teargassing Protesters during an Infectious Outbreak Is ‘a Recipe for Disaster’
Some scientists call for police to stop using the chemical irritants, which could increase the risk of spreading COVID-19
Widely Used Surgical Masks Are Putting Health Care Workers at Serious Risk
Because high-end N95 masks are scarce, hospitals and other medical centers are using less protective surgical masks
What Recovery From COVID-19 Looks Like
Outcomes vary greatly depending on age and other factors, a pulmonologist explains
Cancer Patients Face Treatment Delays and Uncertainty as Coronavirus Overwhelms Hospitals
Health care providers are delaying “nonessential” surgeries—and that could hurt some patients
Heart Damage in COVID-19 Patients Puzzles Doctors
Up to one in five hospitalized patients have signs of heart injury. Cardiologists are trying to learn whether the virus attacks the organ
